National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016
Year: 2017
Type: article
Study design: Observational Study
Abstract: Eligible participants were born during January 1998-February 2004.Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) represents coverage with ≥1 Tdap dose at age ≥10 years.Meningococcal conjugate vaccine (MenACWY) represents coverage with the quadrivalent meningococcal conjugate vaccine or meningococcal-unknown type vaccine.Coverage with meningococcal type B vaccine is not included in 2016 National Immunization Survey-Teen (NIS-Teen) vaccination coverage estimates.Human papillomavirus (HPV) vaccination coverage includes receipt of any HPV vaccine and does not distinguish between nine-valent (9vHPV), quadrivalent (4vHPV), or bivalent (2vHPV) vaccines.Some adolescents might have received more than the 2 or 3 recommended HPV vaccine doses.Estimates for hepatitis B and measles, mumps, and rubella vaccines represent coverage based on the catch-up schedule for adolescents who are not up to date with these vaccinations.Except as noted, coverage estimates for ≥1 and ≥2 varicella vaccine doses were obtained among adolescents with no history of varicella disease.Influenza vaccination coverage
Language: English
Subfield: Health
Field: Social Sciences
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W2916890405
